These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3838784)

  • 41. [Molsidomine prevention of coronary artery spasm caused by alkalosis].
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):545-9. PubMed ID: 6689397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
    Messin R; Demaret B; Denolin H
    Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute double blind trial of a new anti-anginal drug: molsidomine.
    Guerchicoff S; Vazquez A; Kunik H; Drajer S; Díaz F
    Eur J Clin Pharmacol; 1978 Jun; 13(4):247-50. PubMed ID: 352706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intravenous administration of molsidomin in the acute period of myocardial infarct].
    Kipshidze NN; Chapidze GE; Marsagishvili LA; Kapanadze SD; Avalishvili LA
    Kardiologiia; 1985 Aug; 25(8):40-3. PubMed ID: 3840851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of metoprolol with molsidomine in the treatment of angina pectoris.
    van Mantgem JP; Lie KI; Matroos AW
    Eur J Clin Pharmacol; 1985; 28(2):109-11. PubMed ID: 3838725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].
    Slany J; Mösslacher H; Schmoliner R; Krinik G
    Med Welt; 1976 Dec; 27(49):2396-2400. PubMed ID: 796622
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molsidomin and intraocular pressure. No effect in healthy subjects and in glaucoma patients].
    Leydhecker W
    Fortschr Med; 1978 Nov; 96(44):2264-5. PubMed ID: 101432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 51. [Other drugs used in angina pectoris].
    Combes P; Richard M; Fargnoli JM
    Soins Cardiol; 1985 Dec; (34):27-32. PubMed ID: 3854549
    [No Abstract]   [Full Text] [Related]  

  • 52. [Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].
    Furkalo NK; Ivashchenko TI; Romanenko AI
    Kardiologiia; 1985 Sep; 25(9):55-9. PubMed ID: 3935849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hemodynamic effects of molsidomine in chronic cardiac decompensation].
    Hoffmann E; Traina M; Alfano R; Piraino GL; Raineri A
    Boll Soc Ital Cardiol; 1981; 26(11):1485-92. PubMed ID: 6897512
    [No Abstract]   [Full Text] [Related]  

  • 54. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass].
    Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E
    Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of molsidomine on hemodynamics for the patients with chronic heart failure (author's transl)].
    Hayasaki K; Tokunaga M; Kodama H; Kikuchi H; Matsunaga K; Ogata A; Ogawa T
    Kokyu To Junkan; 1981 Mar; 29(3):305-10. PubMed ID: 6894802
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease.
    Ostrowski J; Gaul G; Voegele D; Brockmeier D; Resag K
    Eur J Clin Pharmacol; 1985; 28(5):611-3. PubMed ID: 3899679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
    Nishikawa M; Kanamori M; Hidaka H
    J Pharmacol Exp Ther; 1982 Jan; 220(1):183-90. PubMed ID: 6118429
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of korvatone on the hemodynamic indices of rheumatism patients].
    Sokolov AM; Suloeva MN
    Vrach Delo; 1984 Jul; (7):83-6. PubMed ID: 6548064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.